Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Category: Science Blog December 17, 2014
In the second part of this two-part series, we look at our work with industry, why it’s important, and how we try to influence the way drugs get to patients.
Category: Science Blog December 16, 2014
In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.
Category: Science Blog April 9, 2014
Concluding our story on Epstein-Barr virus and cancer, we explore the ongoing research into the virus and how this could lead to treatments in the future.